Karthik Ramasamy

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 33

Top Venues

European journal of haematology

British journal of haematology

Blood cancer journal

EJHaem

NIHR Clinical Research Network

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NIHR Clinical Research Network Jan 01 2015

United Kingdom

Cancer Divisional Lead :: Cancer

Oxford University Hospitals NHS Foundation Trust Jun 01 2011

United Kingdom

Consultant :: Haematology

Publications

Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology 204 (4) (2024)
Catherine S Y Lecat, Eileen Mary Boyle, Daniel Hughes, Lydia S H Lee, Dean Smith, Ceri A Bygrave, Karthik Ramasamy, Kwee L Yong
Challenges in designing and running smouldering myeloma interventional clinical trials. EJHaem 5 (2) (2024)
Catherine S Y Lecat, Eileen Mary Boyle, Daniel Hughes, Lydia S H Lee, Dean Smith, Ceri A Bygrave, Karthik Ramasamy, Kwee L Yong
Challenges in designing and running smouldering myeloma interventional clinical trials. EJHaem 5 (2) (2024)
Hans C Lee, Karthik Ramasamy, Margaret Macro, Faith E Davies, Rafat Abonour, Frits van Rhee, Vania T M Hungria, Noemi Puig, Kaili Ren, Jiri Silar, Victoria Enwemadu, Dasha Cherepanov, Xavier Leleu
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study. European journal of haematology 113 (2) (2024)
Catherine S Y Lecat, Eileen Mary Boyle, Daniel Hughes, Lydia S H Lee, Dean Smith, Ceri A Bygrave, Karthik Ramasamy, Kwee L Yong
Challenges in designing and running smouldering myeloma interventional clinical trials. EJHaem 5 (2) (2024)
Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology (2024)
Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology 204 (4) (2024)
Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology (2024)
Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology 204 (4) (2024)
Hans C Lee, Karthik Ramasamy, Margaret Macro, Faith E Davies, Rafat Abonour, Frits van Rhee, Vania T M Hungria, Noemi Puig, Kaili Ren, Jiri Silar, Victoria Enwemadu, Dasha Cherepanov, Xavier Leleu
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study. European journal of haematology (2024)
Clement Twumasi, Sally Moore, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Gaurav Agarwal, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Vicky Gamble, Curly T C M Morris, Chara Kyriakou, Mark T Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad Kassim Javaid, Karthik Ramasamy
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination. European journal of haematology 112 (4) (2023)
Edmund Watson, Karthik Ramasamy
Flicking the switch in myeloma MRD. Blood 141 (6) (2023)
Clement Twumasi, Sally Moore, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Gaurav Agarwal, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Vicky Gamble, Curly T C M Morris, Chara Kyriakou, Mark T Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad Kassim Javaid, Karthik Ramasamy
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination. European journal of haematology (2023)
Moritz Lehne, K Martin Kortüm, Karthik Ramasamy, Elena Zamagni, Tim d'Estrubé, Evi Zhuleku, Maya Hanna, Soham Shukla, Marco Ghiani, Ulf Maywald, Thomas Wilke, Lenka Kellermann, Sue Perera
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain. European journal of haematology 112 (5) (2023)
Edmund Watson, Karthik Ramasamy
Flicking the switch in myeloma MRD. Blood 141 (6) (2023)
Clement Twumasi, Sally Moore, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Gaurav Agarwal, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Vicky Gamble, Curly T C M Morris, Chara Kyriakou, Mark T Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad Kassim Javaid, Karthik Ramasamy
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination. European journal of haematology 112 (4) (2023)
Karthik Ramasamy, Hervé Avet-Loiseau, Cecilie Hveding Blimark, Michel Delforge, Francesca Gay, Salomon Manier, Joaquín Martinez-Lopez, Maria Victoria Mateos, Mohamad Mohty, Niels W C J van de Donk, Katja Weisel
Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study. HemaSphere 7 (9) (2023)
Moritz Lehne, K Martin Kortüm, Karthik Ramasamy, Elena Zamagni, Tim d'Estrubé, Evi Zhuleku, Maya Hanna, Soham Shukla, Marco Ghiani, Ulf Maywald, Thomas Wilke, Lenka Kellermann, Sue Perera
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain. European journal of haematology 112 (5) (2023)
Moritz Lehne, K Martin Kortüm, Karthik Ramasamy, Elena Zamagni, Tim d'Estrubé, Evi Zhuleku, Maya Hanna, Soham Shukla, Marco Ghiani, Ulf Maywald, Thomas Wilke, Lenka Kellermann, Sue Perera
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain. European journal of haematology (2023)
Noopur S Raje, Kenneth C Anderson, Hermann Einsele, Yvonne Efebera, Francesca Gay, Sarah P Hammond, Alexander M Lesokhin, Sagar Lonial, Heinz Ludwig, Phillipe Moreau, Krina Patel, Karthik Ramasamy, Maria-Victoria Mateos-Manteca
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel. Blood cancer journal 13 (1) (2023)
Edmund Watson, Faouzi Djebbari, Alexandros Rampotas, Karthik Ramasamy
BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse events. Expert review of hematology 15 (6) (2022)
Sarah Gooding, Naser Ansari-Pour, Mohammad Kazeroun, Kubra Karagoz, Ann Polonskaia, Mirian Salazar, Evie Fitzsimons, Korsuk Sirinukunwattana, Selina Chavda, Maria Ortiz Estevez, Fadi Towfic, Erin Flynt, William Pierceall, Daniel Royston, Kwee L Yong, Karthik Ramasamy, Paresh Vyas, Anjan Thakurta
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma. Blood 140 (16) (2022)
Karthik Ramasamy, Ross Sadler, Sally Jeans, Paul Weeden, Sherin Varghese, Alison Turner, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Curly T C M Morris, Chara Kyriakou, Mark Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, Muhammad K Javaid
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response. British journal of haematology 197 (3) (2022)
Karthik Ramasamy, Gulnaz Iqbal, Richard Brouwer, Victoria Stalker, Salma Akhtar, Sherin Varghese, Jindriska Lindsay, Stephen Schey, Mark T Drayson, Janet Dunn
Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial. Blood cancer journal 12 (11) (2022)
Hannah Patrick, Karthik Ramasamy, Sabia Rashid
Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safety. European journal of haematology 109 (3) (2022)
Karthik Ramasamy, Ajay K Nooka, Hang Quach, Myo Htut, Rakesh Popat, Michaela Liedtke, Sascha A Tuchman, Jacob P Laubach, Cristina Gasparetto, Asher Chanan-Khan, Mark Hertzberg, Mark deMario, Eveline Nueesch, Evelyne Chesne, Izolda Franjkovic, Katharina Lechner, Martin Kornacker, Hearn Jay Cho
A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma. Blood cancer journal 11 (9) (2021)
Kenneth C Anderson, Daniel Auclair, Stacey J Adam, Amit Agarwal, Melissa Anderson, Herve Avet-Loiseau, Mark Bustoros, Jessica R Chapman, Dana E Connors, Ajeeta B Dash, Alessandra Di Bacco, Ling Du, Thierry Facon, Juan A Flores-Montero, Francesca Gay, Irene M Ghobrial, Nicole J Gormley, Ira Gupta, Howard Higley, Jens Hillengass, Bindu Kanapuru, Dickran Kazandjian, Gary J Kelloff, Ilan R Kirsch, Brandon E Kremer, Carl Ola Landgren, Elizabeth D Lightbody, Oliver C Lomas, Sagar Lonial, Maria Victoria Mateos, Rocio Montes de Oca, Lata Mukundan, Nikhil C Munshi, Elizabeth K O'Donnell, Alberto Orfao, Bruno Paiva, Reshma Patel, Trevor J Pugh, Karthik Ramasamy, Jill Ray, Mikhail Roshal, Jeremy A Ross, Caroline C Sigman, Katie L Thoren, Suzanne Trudel, Gary A Ulaner, Nancy Valente, Brendan M Weiss, Elena Zamagni, Shaji K Kumar
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Oliver C Lomas, Matthew Streetly, Guy Pratt, Jim Cavet, Daniel Royston, Stephen Schey, Karthik Ramasamy, null null
The management of Castleman disease. British journal of haematology 195 (3) (2021)
Karthik Ramasamy, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Jemma Larham, Nathanael Gray, Joe Barrett, Stella Bowcock, Curly T C M Morris, Chara Kyriakou, Dean Smith, Mark Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, Muhammad K Javaid
COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma. British journal of haematology (2021)
Ankur Jain, Richard Haynes, Jaimal Kothari, Akhil Khera, Maria Soares, Karthik Ramasamy
Pathophysiology and management of monoclonal gammopathy of renal significance. Blood advances 3 (15) (2020)
Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, Jiří Minařík, Ioannis Ntanasis-Stathopoulos, Eirini Katodritou, Matthew W Jenner, Hana Plonkova, Maria Gavriatopoulou, Grant D Vallance, Tomas Pika, Maria Kotsopoulou, Jaimal Kothari, Tomas Jelinek, Efstathios Kastritis, Robin Aitchison, Meletios- Athanasios Dimopoulos, Athanasios Zomas, Roman Hájek
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma. Annals of hematology 99 (5) (2020)
Faye A Sharpley, Faouzi Djebbari, Samih Fourali, Jaimal Kothari, John A Lynes, Susan McLain-Smith, Karthik Ramasamy
Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma. Leukemia & lymphoma 61 (3) (2019)
Akhil Khera, Fotios P Panitsas, Faouzi Djebbari, Katja Kimberger, Simon Stern, John Quinn, Neil Rabin, Jaimal Kothari, Bassam Alchi, Richard Haynes, Christopher Winearls, Ian Roberts, Karthik Ramasamy
Long term outcomes in monoclonal gammopathy of renal significance. British journal of haematology 186 (5) (2019)

Karthik Ramasamy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Karthik Ramasamy